Literature DB >> 21035515

Human Vδ1-T cells regulate immune responses by targeting autologous immature dendritic cells.

Sharon Merims1, Pouneh Dokouhaki, Betty Joe, Li Zhang.   

Abstract

Recent studies suggest that tissue resident Vδ1-T cells may downregulate immune responses in human beings. However, the function of peripheral blood Vδ1-T cells and their mechanisms of action remain largely unknown because of their limited numbers and the difficulties encountered in expanding these cells. In this study, we provide direct evidence demonstrating that peripheral human Vδ1-T cells can abrogate adaptive immune responses by direct killing of autologous dendritic cells through a perforin-mediated pathway. These findings advance our basic understanding of this unique T-cell subset.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035515     DOI: 10.1016/j.humimm.2010.10.011

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  Studies of amplification, identification and resistant to maturation characteristics on immature dendritic cells derived from human peripheral blood in vitro.

Authors:  Haiming Xin; Wenxian Yang; Yan Jiang; Yitao Wang; Yalin Tong; Yizhi Peng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-08-15       Impact factor: 2.416

2.  Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer.

Authors:  Chunling Ma; Qunyuan Zhang; Jian Ye; Fang Wang; Yanping Zhang; Eric Wevers; Theresa Schwartz; Pamela Hunborg; Mark A Varvares; Daniel F Hoft; Eddy C Hsueh; Guangyong Peng
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

Review 3.  γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.

Authors:  Kok Fei Chan; Jessica Da Gama Duarte; Simone Ostrouska; Andreas Behren
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.